SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001625101-22-000065
Filing Date
2022-11-10
Accepted
2022-11-10 16:20:10
Documents
13
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20221110x8k.htm   iXBRL 8-K 76477
2 EX-99.1 plse-20221110xex99_1.htm EX-99.1 384065
  Complete submission text file 0001625101-22-000065.txt   597869

Data Files

Seq Description Document Type Size
3 EX-101.SCH plse-20221110.xsd EX-101.SCH 2661
4 EX-101.LAB plse-20221110_lab.xml EX-101.LAB 14514
5 EX-101.PRE plse-20221110_pre.xml EX-101.PRE 10365
7 EXTRACTED XBRL INSTANCE DOCUMENT plse-20221110x8k_htm.xml XML 4671
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 221377549
SIC: 3841 Surgical & Medical Instruments & Apparatus